Paper16282986
Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.
Lamers CH and 5 others. Cancer Gene Ther, 2006. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer. Papers, record 16282986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16282986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Carbonic Anhydrases | Major topic |
| Immunoglobulin Variable Region | Major topic |
| Kidney Neoplasms | Major topic |
| Receptors, Immunologic | Major topic |
| T-Lymphocytes | Major topic |
| Transduction, Genetic | Major topic |
| Virus Assembly | Major topic |
| Carbonic Anhydrase IX | |
| Cell Line | |
| Cells, Cultured | |
| Combined Modality Therapy | |
| Cytotoxicity, Immunologic | |
| Genetic Therapy | |
| Humans | |
| Immunotherapy, Adoptive | |
| Retroviridae | |
| Single-Chain Antibodies |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12574392 | Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. | J Immunol | 2003 | https://conductscience.org/library/papers/12574392 | PubMed |
| 2 | 10356257 | Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans. | Biotechnol Prog | 1999 | https://conductscience.org/library/papers/10356257 | PubMed |
| 3 | 18432682 | Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. | Curr Protoc Immunol | 2001 | https://conductscience.org/library/papers/18432682 | PubMed |
| 4 | 9973498 | Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. | J Immunol | 1999 | https://conductscience.org/library/papers/9973498 | PubMed |
| 5 | 12881303 | Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. | Blood | 2003 | https://conductscience.org/library/papers/12881303 | PubMed |
| 6 | 10680014 | Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production. | Gene Ther | 2000 | https://conductscience.org/library/papers/10680014 | PubMed |
| 7 | 12082462 | Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer. | Cancer Gene Ther | 2002 | https://conductscience.org/library/papers/12082462 | PubMed |
| 8 | 15471217 | Adoptive immuno-gene therapy of cancer with single chain antibody [scFv(Ig)] gene modified T lymphocytes. | J Biol Regul Homeost Agents | 2004 | https://conductscience.org/library/papers/15471217 | PubMed |
| 9 | 9930320 | A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. | Gene Ther | 1998 | https://conductscience.org/library/papers/9930320 | PubMed |
| 10 | 12669036 | Safety of retroviral gene marking with a truncated NGF receptor. | Nat Med | 2003 | https://conductscience.org/library/papers/12669036 | PubMed |
| 11 | 14741772 | Chance or necessity? Insertional mutagenesis in gene therapy and its consequences. | Mol Ther | 2004 | https://conductscience.org/library/papers/14741772 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40764385 | Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function. | Nat Commun | 2025 | https://conductscience.org/library/papers/40764385 | PubMed |
| 39172012 | TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer. | Cancer Discov | 2024 | https://conductscience.org/library/papers/39172012 | PubMed |
| 38673757 | Car T Cells in Solid Tumors: Overcoming Obstacles. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673757 | PubMed |
| 35622329 | Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35622329 | PubMed |
| 29350274 | T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression. | Acta Neuropathol | 2018 | https://conductscience.org/library/papers/29350274 | PubMed |
| 27096098 | Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. | J Immunother Cancer | 2016 | https://conductscience.org/library/papers/27096098 | PubMed |
| 26824221 | Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin. | Pigment Cell Melanoma Res | 2016 | https://conductscience.org/library/papers/26824221 | PubMed |
| 25423330 | T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness. | Hum Gene Ther Methods | 2014 | https://conductscience.org/library/papers/25423330 | PubMed |
| 24027572 | An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT. | Front Immunol | 2013 | https://conductscience.org/library/papers/24027572 | PubMed |
| 23423337 | Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity. | Mol Ther | 2013 | https://conductscience.org/library/papers/23423337 | PubMed |
| 22871260 | Magnetic-activated cell sorting of TCR-engineered T cells, using tCD34 as a gene marker, but not peptide-MHC multimers, results in significant numbers of functional CD4+ and CD8+ T cells. | Hum Gene Ther Methods | 2012 | https://conductscience.org/library/papers/22871260 | PubMed |
| 22400038 | TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/22400038 | PubMed |
| 18202714 | Retroviral vectors for clinical immunogene therapy are stable for up to 9 years. | Cancer Gene Ther | 2008 | https://conductscience.org/library/papers/18202714 | PubMed |
| 17479266 | Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/17479266 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CA9 | 768 | PubTator's text mining | https://conductscience.org/library/genes/768 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16282986
GET https://conductscience.org/api/papers/v1/16282986/authors